PosterSessionOnline

13th International Conference on Malignant Lymphoma

17-20 June 2015 Lugano

About us


Discussion forum - 13th International Conference on Malignant Lymphoma Topic - Ongoing trials If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER

Thread / Poster	Author	Replies	Last reply

FIL-VERAL12: phase II randomized study with Rituximab-DHAP /- Bortezomib as induction in young relapsed/refractory Diffuse Large B-cell Lymphoma eligible to transplant.	ANNALISA CHIAPPELLA	1	6/8/2015 11:15:00 PM


Phase I dose-escalation study of BI 836826 in patients (pts) with relapsed or refractory non-Hodgkin lymphoma (NHL) of B cell origin	Frank Kroschinsky	1	6/8/2015 6:17:00 PM


First in-patient proof of safety and efficacy of a 4th generation chimeric antigen receptor-modified T cells for the treatment of R/R CD30-positive lymphoma	Zhitao Ying	1	6/8/2015 6:11:00 PM


The Elderly Project by the Fondazione Italiana Linfomi (FIL): A Prospective Multidimensional Assessment of Eldelry Patients with Diffuse Large B-Cell Lymphoma.	MERLI FRANCESCO	1	6/8/2015 11:48:00 AM


CLLR3 A randomized Phase II trial evaluating the chemotherapies FC/ B combined with GA101 followed by GA101 maintenance in relapsed/ refractory CLL	Nadine Kutsch	1	6/6/2015 11:38:00 PM


Most viewed poster for this congress

Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center


Poster most viewed in this topic

Poster: 14
Visits: 271
Title: CLLR3 A randomized Phase II trial evaluating the chemotherapies FC/ B combined with GA101 followed by GA101 maintenance in relapsed/ refractory CLL
Authors: Nadine Kutsch ,
Centre: University Hospital of Cologne

About us

Terms and Conditions

Special Access

Commercial Web Access